Home › Funds › RTW INVESTMENTS, LP › STOK
RTW INVESTMENTS, LP position in STOK
STOKE THERAPEUTICS INC · Health Care
RTW INVESTMENTS, LP reported holding 5,623,525 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$146.2M, representing 1.48% of its reported portfolio and ranking #23 among its reported holdings. RTW INVESTMENTS, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's STOK position evolved
RTW INVESTMENTS, LP first disclosed a stake in STOK in Q3 2023 at 4,390,558 shares (US$17.3M). The position peaked in Q2 2026 at 5,623,525 shares, worth US$184.0M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 5,623,525 shares valued at US$146.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.39M | $17.30M | New |
| Q4 2023 | 4.13M | $21.73M | Reduce |
| Q1 2024 | 4.22M | $57.04M | Add |
| Q2 2024 | 4.22M | $57.08M | Hold |
| Q3 2024 | 4.65M | $57.18M | Add |
| Q4 2024 | 5.12M | $56.51M | Add |
| Q1 2025 | 5.12M | $34.07M | Hold |
| Q2 2025 | 5.12M | $58.15M | Hold |
| Q3 2025 | 5.12M | $120.40M | Hold |
| Q4 2025 | 5.55M | $176.06M | Add |
| Q1 2026 | 5.62M | $183.10M | Add |
| Q2 2026 | 5.62M | $184.00M | Hold |
| Q3 2026 | 5.62M | $146.21M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in STOK — the largest reported positions include Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M), BAKER BROS. ADVISORS LP (US$109.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M sh · $103.83M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- Siren, L.L.C. 2.00M sh · $51.88M · Q3 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- EcoR1 Capital, LLC 835.00K sh · $21.71M · Q3 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 300.00K sh · $9.82M · Q2 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held STOK?
RTW INVESTMENTS, LP has disclosed STOK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in STOK?
As of Q3 2026, RTW INVESTMENTS, LP holds 5.62M shares of STOK (STOKE THERAPEUTICS INC), valued at $146.21M, representing 1.48% of its reported portfolio and ranking #23.
Has RTW INVESTMENTS, LP been buying or selling STOK?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in STOK. The position peaked in Q2 2026 at 5.62M shares.
Which other funds hold STOK?
Other major institutional holders of STOK include Lynx1 Capital Management LP, Redmile Group, LLC, BAKER BROS. ADVISORS LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.